Dr. Shivananda Murgod E et al. 2023. EFFICACY OF SOFOSBUVIR/DACLATASVIR IN CIRRHOTIC AND NON-CIRRHOTIC PATIENTS WITH HCV GENOTYPE 4 INFECTION AT A SPECIALIST HOSPITAL. Journal of Population Therapeutics and Clinical Pharmacology. 30, 18 (Nov. 2023), 2818–2823. DOI:https://doi.org/10.53555/jptcp.v30i18.3544.